Federal Judge Upholds $42 Million Verdict Against Boston Scientific in Stent Patent Case, Dismisses Willful Infringement

A Delaware federal judge recently ruled that Boston Scientific is not entitled to a new trial in a patent infringement case resulting in a $42 million verdict against the company. The case revolves around stent systems technology, and the court found no grounds to overturn the jury’s decision on damages. However, the judge dismissed a previous finding of willful infringement, which could have increased the financial penalties for Boston Scientific. For more details on this ruling, visit the original article.